Rewards for Tuberculosis Contact Screening
RECON
3 other identifiers
interventional
301
1 country
2
Brief Summary
This pilot project is an evaluation of the feasibility, acceptability, and cost of offering an economic reward, in the form of a shopping voucher, to the household contacts of index patients (outpatient drug-susceptible and drug-resistant TB patients) who present at the study clinic for TB screening and optional HIV testing, providing a reward to the index patients for participating, and entering index patients whose contacts do present into a lottery to win a prize.The effectiveness of the intervention in screening a high proportion of contacts will be compared to existing published data from studies of active case-finding through home visits and of the status quo passive case finding. If successful, this pilot project will create a demand for screening among high risk patients, who will be rewarded for identifying themselves to the healthcare system, and could prove to be an affordable alternative to resource-intensive home visits. It will also shift responsibility for contact tracing from overburdened clinic staff to those who have the most to gain from early case detection-the patients and their families.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2014
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2014
CompletedFirst Posted
Study publicly available on registry
September 9, 2014
CompletedStudy Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedJanuary 8, 2021
January 1, 2021
1.3 years
September 5, 2014
January 7, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of household contacts volunteering for TB symptom screening
The primary quantitative outcome is uptake of TB symptom screening, defined as the proportion of reported household contacts who complete TB symptom screening within 1 month of index subject enrollment.
30 days
Study Arms (2)
Contacts
EXPERIMENTALContacts are the household contacts of confirmed TB and drug-resistant TB patients.
Index
OTHERIndex subjects are confirmed TB and drug-resistant TB patients who distribute referral cards to their household contacts.
Interventions
Household contacts who come to the study clinic, present a referral card, and complete TB symptom screening will receive a shopping voucher of $5-10 value.
Index subjects will be entered in a prize lottery if any of their contacts complete TB symptom screening at the study clinic.
Eligibility Criteria
You may qualify if:
- Adult patients (\>18 years)
- Newly diagnosed with pulmonary TB (drug-susceptible or drug-resistant) or initiating treatment for TB at one of the study sites
You may not qualify if:
- Resident outside the site's permissible catchment area for service delivery
- No household contacts (live alone)
- Admitted for inpatient care immediately following their TB diagnosis, and thus not readily able to distribute the referral cards
- Not physically, mentally, or emotionally able to participate in the study, in the view of study staff
- Previously enrolled in the same study
- Declines to provide written informed consent to participate
- Unable to speak any of the languages for which consent documents are available and not accompanied by person who can
- Usually spend at least 4 nights per week in the same household as an index case
- Can provide referral card given to contact by index patient
- Currently on any type of TB treatment
- Not able to present any form of identification that matches the information on the referral card
- Previously enrolled in the same study
- Declines to provide written informed consent to participate
- Unable to speak any of the languages for which consent documents are available and not accompanied by person who can
- Experience with the intervention as provider or patient
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Universitylead
- University of Witwatersrand, South Africacollaborator
- City of Johannesburgcollaborator
- Helen Joseph Hospitalcollaborator
- National Institute of Allergy and Infectious Diseases (NIAID)collaborator
Study Sites (2)
Helen Joseph Hospital
Johannesburg, 2193, South Africa
OR Tambo Clinic
Johannesburg, South Africa
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sydney Rosen
Boston University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2014
First Posted
September 9, 2014
Study Start
October 1, 2014
Primary Completion
January 1, 2016
Study Completion
December 1, 2016
Last Updated
January 8, 2021
Record last verified: 2021-01